First study of neoadjuvant use of PARP inhibitor shows promise forearly-stage, BRCA+ breast cancer patients
The University of Texas MD Anderson Cancer Center News | Jun 06, 2018
Updated ALEX trial results show alectinib further outpacing crizotinib in treatment-naive ALK+ NSCLC
University of Colorado Health News | Jun 06, 2018
TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
Albert Einstein College of Medicine | Jun 06, 2018
Erdafitinib shows promise in urothelial cancer patients with specific mutations
The University of Texas MD Anderson Cancer Center News | Jun 06, 2018
Long-term IMPACT data find improved survival when targeted therapiesmatched to tumor-specific gene mutations
The University of Texas MD Anderson Cancer Center News | Jun 06, 2018
Phase 1 trial finds experimental drug safe in treating CLL
UC San Diego Health System News | Jun 05, 2018
Ticks on migratory birds found to carry newly discovered hemorrhagic fever virus
Uppsala University News | Jun 05, 2018
Penn-developed approach could limit toxicity of CAR T-cell therapy in AML
Penn Medicine News | Jun 05, 2018
A call for doctors to lead the charge for antibiotic-free foods
Johns Hopkins Medicine News | Jun 04, 2018